Advanced Search

 

Study ID Status Title Patient Level Data
202012 Completed PRJ2429: Effect of inhaled corticosteroid (ICS) particle size on asthma efficacy and safety outcomes: A systematic literature review and meta-analysis
202024 Not yet recruiting An open label, multi-centre, post marketing surveillance (PMS) to monitor the safety and effectiveness of Benlysta administered in Korean subjects with SLE
202026 Not yet recruiting LAMICTAL Special Drug Use Investigation(mono-therapy for Typical Absence Seizure)
202029 Recruiting ZAGALLO Capsules Drug Use Investigation
202031 Terminated A double-blind (sponsor unblind), randomized, placebo-controlled, single and repeat escalating dose study to investigate the safety, tolerability, and pharmacokinetics of CCI15106 capsules for inhalation in healthy subjects and patients with moderate chronic obstructive pulmonary disease (COPD)
202033 Recruiting Prospective Non-Interventional observational Study of use of Triumeq® and corresponding monitoring measures in clinical practice in Germany
202050 Completed PGx7607: PGx evaluation of pyrexia by meta-analysis of melanoma subjects from BRF113710, BRF113929, BRF113683, MEK115306 and MEK116513
202051 Completed PGX7608: PGx evaluation of efficacy of dabrafenib and trametinib by meta-analysis of melanoma subjects from BRF113710, BRF113929, BRF113683, MEK114267, MEK115306 and MEK116513
202055 Completed European Medicines Agency (EMA) post-authorisation safety study of influenza vaccine
202056 Completed Post-authorisation passive enhanced safety surveillance of seasonal influenza vaccines: Pilot study in England
202062 Recruiting A single-centre, double-blind (sponsor open), placebo controlled two part study to evaluate the safety, tolerability and pharmacokinetics of single and repeat doses of GSK2292767 as a dry powder in healthy participants who smoke cigarettes
202063 Completed Additional subgroup analysis of onabotulinumtoxinA phase III trial in post-stroke patients with upper limb spasticity
202090 Active not recruiting Safety and immunogenicity study of GSK Biologicals’ investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (GSK3390107A) in children in Africa
202091 Completed Safety and immunogenicity study of GSK Biologicals’ investigational recombinant chimpanzee adenovirus Type 3-vectored Ebola Zaire vaccine (GSK3390107A) in adults in Africa
202093 Completed A Phase 2a Study to Evaluate the Pharmacokinetic, Safety, Tolerability and Clinical Effect of Topically Applied Umeclidinium/GSK573719 in Subjects with Primary Axillary Hyperhidrosis
202094 Active not recruiting An evaluation of bone mineral density in HIV-1-infected adult subjects switching from a tenofovir-containing antiretroviral therapy regimen to a dolutegravir plus rilpivirine regimen
202105 Recruiting An open label non randomized access study of trametinib for patients with advanced unresectable (stage IIIc) or distant metastatic (stage IV) BRAF V600E/K mutation positive cutaneous melanoma
202115 Completed Can social listening data be used to provide meaningful insights into potential abuse of bupropion?
202121 Completed PGx7635: Meta-analysis of data from FCGR PGx evaluations of ofatumumab DLBCL studies
202122 Completed PGx7597: Meta-analyses of data from FCGR PGx evaluations of ofatumumab CLL studies
202146 Not yet recruiting HO-15-15509 - Adelphi survey Benlysta effectiveness
202152 Recruiting A multicentre, randomised, double-blind (sponsor unblinded), placebo-controlled study with open label extension to investigate the safety and tolerability, pharmacokinetics, pharmacodynamics, and efficacy of GSK2982772 in subjects with active ulcerative colitis
202155 Completed A double blind randomised controlled trial in pre-school age children to evaluate the impact of a nutritional beverage powder on cognitive performance measures
202157 Withdrawn Evaluation of the characteristics of Alli® purchasers in the European Union following the revision to the Alli® pack information.
202161 Completed A clinical study investigating the efficacy of a dentifrice in providing immediate and short term relief from dentinal hypersensitivity

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.